Global Pharmacy Automation Systems Market Report 2013-2018
Information contained on this page is provided by an independent third-party content provider. WorldNow and this Station make no warranties or representations in connection therewith. If you have any questions or comments about this page please contact firstname.lastname@example.org.
The report includes strategies and market entry barriers to be considered by individuals and groups who expect to venture into this arena in the coming years. Additionally, the report also includes recommendations for new entrants as well as seasoned players in the market based on current trends, and expected future market trends. To aid in tactical decision making, the report provides competitive profiling of key players, business strategies adopted by them and recent developments in the industry. This study will help suppliers, designers, manufacturers and distributors in the pharmacy automation technologies field to plan and implement their strategies in potential markets and new technologies.
The report segments the pharmacy automation systems market by technologies into automated medication dispensing, automated packaging and labeling, storage and retrieval systems, automated compounding systems and table-top tablet counters. According to major end users, this market is segmented into automation in hospital pharmacies and automation in retail pharmacies. The report also provides an in-depth analysis of current trends, drivers and outlook by geography in the final section.
Key Topics Covered:
2 Executive summary
3 Pharmacy automation market analysis
4 Pharmacy automation market analysis by application, 2012 - 2018
5 Pharmacy automation market analysis, by end users, 2012 - 2018
6 Pharmacy automation market analysis, by geography, 2012 - 2018
Two lots of Pfizer's antidepressant drug Effexor XR (venlafaxine HCl) are being recalled because they may contain capsules of another drug called Tikosyn (dofetilide).More >>
Two lots of Pfizer's antidepressant drug Effexor XR (venlafaxine HCl) are being recalled because they may contain capsules of another drug called Tikosyn (dofetilide), which is used to treat heart rhythm disorders.More >>